SCHEMBL18597902

SCHEMBL18597902

CCOC(=O)C(C)(CO)C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 20/20 0.76
▸ ACE P12821 9/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14891056 1.00 MME (0.76) MMEACE
SCHEMBL20681853 0.88 MME (0.58) MMEACE
SCHEMBL15468114 0.88 MME (0.58) MMEACE
SCHEMBL19753757 0.87 MME (1.00) MMEACE
SCHEMBL14891224 0.87 MME (1.00) MMEACE
SCHEMBL14900586 0.87 MME (1.00) MMEACE
SCHEMBL19705881 0.84 MME (0.62) MMEACE
SCHEMBL18012898 0.84 MME (0.62) MMEACE
SCHEMBL19875571 0.81 MME (0.56) MMEACE
SCHEMBL11969610 0.81 MME (0.56) MMEACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2773335-B1 OXALIC ACID AMIDES AS NEPRILYSIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND PREPARATION THEREOF THERAVANCE BIOPHARMA R&D IP LLC (US) 2017-03-08 — — EP disclosed
Send feedback